{"id":"W3130302511","doi":"10.1016/j.esmoop.2020.100043","title":"Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial","year":2021,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"Medical Research Council; Canadian Cancer Society Research Institute; Cancer Research UK; Cancer Australia; Canadian Cancer Society; AstraZeneca","keywords":"Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Chemotherapy; Placebo; Ovarian cancer; Maintenance therapy; Progression-free survival; Oncology; Randomized controlled trial; Confidence interval; Surgery; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005451408,0.0001900969,0.0008188608,0.00007585729,0.00004583047,0.00003939376,0.00008961296,0.0000864,0.00072783],"category_scores_gemma":[0.0001527584,0.0001529546,0.00007955563,0.0002467759,0.00002738079,0.0001052649,0.00003413338,0.0001011598,0.000002329353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000385715,"about_ca_system_score_gemma":0.0006795952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002563731,"about_ca_topic_score_gemma":0.002324178,"domain_scores_codex":[0.9984203,0.00009977456,0.0004986991,0.0004681341,0.0002341773,0.0002789045],"domain_scores_gemma":[0.9987777,0.000340148,0.000199668,0.0003205372,0.0002092851,0.0001526999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9750944,0.001815677,0.00009850386,0.00003725372,0.0006987495,0.0001591009,0.004175573,0.00004271283,0.0009156217,0.0002047052,0.004621334,0.01213638],"study_design_scores_gemma":[0.9560712,0.004163835,0.006376031,0.000496418,0.0001263661,0.000005591141,0.0004558116,0.00007513902,0.02271698,0.00009352302,0.009231762,0.0001873305],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742157,0.00002134911,0.0001947067,0.007243156,0.000361827,0.008305881,0.001118531,0.00001784013,0.008520992],"genre_scores_gemma":[0.9918178,0.00005689075,0.001436234,0.001151923,0.0003078395,0.002846313,0.0004454161,0.00003889225,0.001898668],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02180135,"threshold_uncertainty_score":0.7969228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03323966290094998,"score_gpt":0.3371386250839932,"score_spread":0.3038989621830432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}